May 13 (Reuters)- Immuno Biological Laboratories Co Ltd PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Mar 31, 2026 Mar 31, 2025 Mar 31, 2027 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST Sales 1.00 959 mln (+4.4 pct) (+18.1 pct) Operating 285 mln 207 mln (+37.7 pct) (+83.9 pct) Recurring 316 mln 219 mln (+44.0 pct) (+50.8 pct) Net 319 mln 249 mln (+28.2 pct) (+33.4 pct) EPS 34.27 yen 26.74 yen Ann Div 6.00 yen NIL 7.50 yen -Q2 Div NIL NIL NIL -Q4 Div 6.00 yen NIL 7.50 yen NOTE - Immuno Biological Laboratories Co Ltd. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T